Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders

[1]  G. Francis,et al.  Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia. , 2019, Journal of the American College of Cardiology.

[2]  T. Hankemeier,et al.  Genome-wide association study of plasma lipids , 2019, bioRxiv.

[3]  Gonçalo Abecasis,et al.  Whole exome sequencing and characterization of coding variation in 49,960 individuals in the UK Biobank , 2019, bioRxiv.

[4]  N. Wald,et al.  The illusion of polygenic disease risk prediction , 2019, Genetics in Medicine.

[5]  Michael D. Edge,et al.  Interpreting polygenic scores, polygenic adaptation, and human phenotypic differences , 2018, Evolution, medicine, and public health.

[6]  Tanya M. Teslovich,et al.  Genetics of Blood Lipids Among ~300,000 Multi-Ethnic Participants of the Million Veteran Program , 2018, Nature Genetics.

[7]  J. Tyrrell,et al.  Mosaic Turner syndrome shows reduced penetrance in an adult population study , 2018, Genetics in Medicine.

[8]  Laney K. Jones,et al.  Healthcare Utilization and Patients’ Perspectives After Receiving a Positive Genetic Test for Familial Hypercholesterolemia: A Pilot Study , 2018, Circulation. Genomic and precision medicine.

[9]  T. Mirshahi,et al.  Genetic variants help define the role of the MC4R C-terminus in signaling and cell surface stability , 2018, Scientific Reports.

[10]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[11]  E. Topol,et al.  The personal and clinical utility of polygenic risk scores , 2018, Nature Reviews Genetics.

[12]  F. D. Davis,et al.  Patient-Centered Precision Health In A Learning Health Care System: Geisinger's Genomic Medicine Experience. , 2018, Health affairs.

[13]  Caroline F. Wright,et al.  Common genetic variants contribute to risk of rare severe neurodevelopmental disorders , 2018, Nature.

[14]  P. Visscher,et al.  Meta-analysis of genome-wide association studies for height and body mass index in ∼700,000 individuals of European ancestry , 2018, bioRxiv.

[15]  Shuwen Huang,et al.  Incomplete penetrance, variable expressivity, or dosage insensitivity in four families with directly transmitted unbalanced chromosome abnormalities , 2018, American journal of medical genetics. Part A.

[16]  May E. Montasser,et al.  Deep-coverage whole genome sequences and blood lipids among 16,324 individuals , 2017, Nature Communications.

[17]  Raquel S. Sevilla,et al.  Exome-wide association study of plasma lipids in >300,000 individuals , 2017, Nature Genetics.

[18]  Alexander E. Lopez,et al.  Profiling and leveraging relatedness in a precision medicine cohort of 92,455 exomes , 2017, bioRxiv.

[19]  Yadav Sapkota,et al.  CNV-association meta-analysis in 191,161 European adults reveals new loci associated with anthropometric traits , 2017, Nature Communications.

[20]  Yang I Li,et al.  An Expanded View of Complex Traits: From Polygenic to Omnigenic , 2017, Cell.

[21]  G. Paré,et al.  Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia. , 2017, Journal of clinical lipidology.

[22]  Marc S. Williams,et al.  Adding Protective Genetic Variants to Clinical Reporting of Genomic Screening Results: Restoring Balance , 2017, JAMA.

[23]  Marylyn D. Ritchie,et al.  Profiling copy number variation and disease associations from 50,726 DiscovEHR Study exomes , 2017, bioRxiv.

[24]  Rasool Tahmasbi,et al.  Comparison of methods that use whole genome data to estimate the heritability and genetic architecture of complex traits , 2017, Nature Genetics.

[25]  W. Chung,et al.  Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers , 2017, Journal of the National Cancer Institute.

[26]  Lilah M. Besser,et al.  Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score , 2017, PLoS medicine.

[27]  Dustin N. Hartzel,et al.  Genetic identification of familial hypercholesterolemia within a single U.S. health care system , 2016, Science.

[28]  Marylyn D. Ritchie,et al.  Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study , 2016, Science.

[29]  N. Katsanis.  The continuum of causality in human genetic disorders , 2016, Genome Biology.

[30]  G. Tirabassi,et al.  Klinefelter syndrome (KS): genetics, clinical phenotype and hypogonadism , 2016, Journal of Endocrinological Investigation.

[31]  Alan M. Kwong,et al.  Next-generation genotype imputation service and methods , 2016, Nature Genetics.

[32]  K. Flegal,et al.  Anthropometric Reference Data for Children and Adults: United States, 2011-2014. , 2016, Vital and health statistics. Series 3, Analytical studies.

[33]  Shane A. McCarthy,et al.  Reference-based phasing using the Haplotype Reference Consortium panel , 2016, Nature Genetics.

[34]  C. Lindgren,et al.  Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease , 2016, American journal of human genetics.

[35]  Jianxin Shi,et al.  Developing and evaluating polygenic risk prediction models for stratified disease prevention , 2016, Nature Reviews Genetics.

[36]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[37]  Alexander E. Lopez,et al.  Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease. , 2016, The New England journal of medicine.

[38]  G. Kirov,et al.  Erratum: Arc expression identifies the lateral amygdala fear memory trace , 2015, Molecular Psychiatry.

[39]  D. Ledbetter,et al.  The Geisinger MyCode Community Health Initiative: an electronic health record-linked biobank for Precision Medicine research , 2015, Genetics in Medicine.

[40]  P. Visscher,et al.  Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores , 2015, bioRxiv.

[41]  G. Kirov,et al.  Common alleles contribute to schizophrenia in CNV carriers , 2015, Molecular Psychiatry.

[42]  Frederick E. Dewey,et al.  CLAMMS: a scalable algorithm for calling common and rare copy number variants from exome sequencing data , 2015, Bioinform..

[43]  David W. Evans,et al.  The role of parental cognitive, behavioral, and motor profiles in clinical variability in individuals with chromosome 16p11.2 deletions. , 2015, JAMA psychiatry.

[44]  Jeffrey Staples,et al.  PRIMUS: rapid reconstruction of pedigrees from genome-wide estimates of identity by descent. , 2014, American journal of human genetics.

[45]  A. González Jaimes,et al.  Homozygous familial hypercholesterolemia: the c.1055G>A mutation in the LDLR gene and clinical heterogeneity. , 2014, Journal of clinical lipidology.

[46]  Adam J. Schwarz,et al.  CNVs conferring risk of autism or schizophrenia affect cognition in controls , 2013, Nature.

[47]  Deanna M. Church,et al.  ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..

[48]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[49]  D. Ledbetter,et al.  Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence , 2013, The Lancet Neurology.

[50]  Heng Li.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[51]  Lyubov Yevtushok,et al.  Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening , 2012, European Journal of Human Genetics.

[52]  N. Tartaglia,et al.  A review of trisomy X (47,XXX) , 2010, Orphanet journal of rare diseases.

[53]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[54]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[55]  Tim Cheetham,et al.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. , 2003, The New England journal of medicine.

[56]  M. Trimble.  Restoring the Balance , 2002, CNS Spectrums.

[57]  I. Glass,et al.  The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. , 2000, Human molecular genetics.

[58]  C. Baird.  The pilot study. , 2000, Orthopedic nursing.

[59]  A. Piquero,et al.  USING THE CORRECT STATISTICAL TEST FOR THE EQUALITY OF REGRESSION COEFFICIENTS , 1998 .

[60]  H. Lipkin.  Where is the ?c? , 1978 .

[61]  A. Prader,et al.  Growth in children with 45,Xo Turner's syndrome , 1974 .

[62]  David W. Smith,et al.  THE XO SYNDROME. A STUDY OF THE DIFFERENTIATED PHENOTYPE IN 25 PATIENTS. , 1963, The Journal of pediatrics.

[63]  P. Elliott,et al.  Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. , 2021 .

[64]  T. Gasser,et al.  Height correlations between parents and mature offspring in normal subjects and in subjects with Turner's and Klinefelter's and other syndromes. , 1977, Annals of human biology.